A Closer Look at Gilead Sciences's Options Market Dynamics
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors have shown a bullish approach towards Gilead Sciences (NASDAQ:GILD), with significant options activity observed. The options market shows a divided sentiment among these investors, with 50% leaning bullish and 50% bearish. The targeted price range for Gilead Sciences over the last 3 months is from $65.0 to $92.5. The company's current trading volume stands at 4,329,152, with its price down by -0.45%, positioned at $77.55. An analyst from Deutsche Bank downgraded its action to Hold with a price target of $75.
November 09, 2023 | 6:32 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Gilead Sciences has seen significant options activity, indicating potential major moves. The sentiment among investors is divided, with a targeted price range of $65.0 to $92.5. Deutsche Bank downgraded its action to Hold with a price target of $75.
The significant options activity indicates that investors are expecting major moves in Gilead Sciences' stock. However, the sentiment is divided, making it difficult to predict the direction of the move. The downgrade by Deutsche Bank could potentially have a negative impact on the stock.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100